Company Directory > Biotech > Primus Pharmaceuticals
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Primus Pharmaceuticals and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Primus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing prescription medical foods, drugs, and medical devices. The company targets metabolic causes of chronic diseases, aiming to provide safe, effective, and science-validated therapeutic options that can be used early in the treatment progression to improve patient quality of life. Primus differentiates itself by specializing in "prescription medical nutrition," utilizing time-tested ingredients to address unmet medical needs in areas such as rheumatology, dermatology, and women's health. Their products are designed to be used under physician supervision and are often positioned as first-line therapies due to their favorable safety profiles compared to traditional pharmaceutical interventions.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Medical Nutrition / Specialty Pharma
SIZE & FINANCIALS
Employees:51-200
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Medical Foods, Small molecule, Topical
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:NattoPharma (collaboration on MenaQ7 vitamin K2 for Fosteum PLUS)
COMPETITION
Position:Niche Player
Competitors:Glycologic, A&Z Pharmaceutical
LEADERSHIP
Key Executives:
James Chivian Lukban - Medical Director
Bruce Burnett - Director Of Medical Education & Scientific/Regulatory Affairs
LINKS
Website:primusrx.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Primus Pharmaceuticals. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.